|
|
Current Data on ATP-Containing Liposomes and Potential Prospects To Enhance Cellular Energy Status for Hepatic Applications
V. Korb
,
K. Tep
,
V. Escriou
,
C. Richard
,
D. Scherman
et al.
Journal articles
hal-03827732v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
D. Scherman
,
A. Rousseau
,
P. Bigey
,
V. Escriou
Journal articles
hal-03292055v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
169 FORMULATION AND EVALUATION OF ATP-CONTAINING LIPOSOMES INCLUDING LACTOSYLATED ASGPR LIGAND TO ENHANCE CELLULAR ENERGY STATUS FOR HEPATIC APPLICATIONS
V. Vincourt
,
K. Tep
,
V. Korb
,
C. Richard
,
V. Escriou
et al.
Journal articles
hal-03828530v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rôle de l’AMPK, mTOR et GCN2 dans la détection des AA dans des hépatocytes en culture primaire
Dalila D. Azzout-Marniche
,
N. Chotechuang
,
D. Singer
,
C. Chaumontet
,
G. Fromentin
et al.
Conference papers
hal-01588513v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model
L. A. Cordova
,
V. Trichet
,
V. Escriou
,
P. Rosset
,
J. Amiaud
et al.
Journal articles
hal-03292707v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|